The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Diabetes Prevention Program (DPP) and its Outcomes Study (DPPOS) demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in high-risk adults for at least 10 years after randomization. We report the 10-year within-trial cost-effectiveness of the interventions. RESEARCH DESIGN AND METHODS: Data on resource utilization, cost, and quality of life were collected prospectively. Economic analyses were performed from health system and societal perspectives. RESULTS: Over 10 years, the cumulative, undiscounted per capita direct medical costs of the interventions, as implemented during the DPP, were greater for lifestyle ($4,572) than metformin ($2,281) or placebo ($752). The cumulative direct medical costs of care outside the DPP/DPPOS were least for lifestyle ($26,810 lifestyle vs. $27,384 metformin vs. $29,007 placebo). The cumulative, combined total direct medical costs were greatest for lifestyle and least for metformin ($31,382 lifestyle vs. $29,665 metformin vs. $29,759 placebo). The cumulative quality-adjusted life-years (QALYs) accrued over 10 years were greater for lifestyle (6.89) than metformin (6.79) or placebo (6.74). When costs and outcomes were discounted at 3% and adjusted for survival, lifestyle cost $12,878 per QALY, and metformin had slightly lower costs and nearly the same QALYs as placebo. CONCLUSIONS: Over 10 years, from a payer perspective, lifestyle was cost-effective and metformin was marginally cost-saving compared with placebo. Investment in lifestyle and metformin interventions for diabetes prevention in high-risk adults provides good value for the money spent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to potential for type 2 diabetes risk reduction, metformin therapy is also a feasible strategy in real world settings, given its association with cost savings. 15”
From Metformin Prescription Rates for Patients with Prediabetes (2022) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both DPP-modeled intensive lifestyle interventions and individualized MNT for prediabetes have demonstrated costeffectiveness (17,36)”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
Does Preventive Care Save Money? Health Economics and the Presidential Candidates
Cohen, J. T., Neumann, P. J., & Weinstein, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0708558 · Cited by 471 · cited 1×
“Unfortunately, fewer than 1 in 5 new interventions in health and medicine are cost-saving compared with usual care (17).”
BackgroundThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.36 · Cited by 358
Self-citationRenjilian, D. A., Perri, M. G., Nezu, A. M., McKelvey, W. F., Shermer, R. L., & Anton, S. D. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.69.4.717 · Cited by 327 · cited 2×
“Studies have shown that group intervention programs can be as effective as individual programs (12,13).”
BackgroundClinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes
Eddy, D. M., Schlessinger, L., & Kahn, R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00006 · Cited by 318 · cited 2×
“However, one analysis suggested that lifestyle might be too expensive for health plans or a national program to implement (10).”
Background
Research works printed but not linked: 1
- Gold MR Siegel JE Russell LB Weinstein MC (Eds.). Cost-effectiveness in health and medicine. New York, Oxford University Press, 1996
Cited by
Items 301–400 of 499
Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk
Chatterjee, S., Davies, M. J., & Khunti, K. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0239-y · Cited by 5
Birse, C. E., Shiffman, D., Satish, A., Fragala, M. S., Arellano, A. R., Castro, C. M., & LAGIER, R. J. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002044 · Cited by 5
Speaking to Patients About Diabetes Risk: Is Terminology Important?
Tarasova, V. D., Caballero, J. A., Turner, P., & Inzucchi, S. E. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.2.90 · Cited by 5
ForgIng New paths in DIabetes PrevenTion (FINDIT): Study Protocol for a Randomized Controlled Trial
Kullgren, J. T., Youles, B., Shetty, S., Richardson, C. R., Fagerlin, A., & Heisler, M. (2017) · Trials · doi:10.1186/s13063-017-1887-6 · Cited by 5
Kamal, R. H., Novendrianto, D., Chadijah, F., Prasetya, G. B., Pratama, G. S., Ariadnya, M. O., Larasati, N. G., Darain, N. L. F., Nanda, O., Mavita, S., et al. (2017) · Folia Medica Indonesiana · doi:10.20473/fmi.v53i3.6448 · Cited by 5
Practical Tips for Implementing the Diabetes Prevention Program in Clinical Practice
Jasik, C. B., Joy, E. A., Brunisholz, K. D., & Kirley, K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1034-0 · Cited by 6
The Role of Behavioral Medicine in Integrated Healthcare
Wilson, D. K., & Sweeney, A. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-93003-9_2 · Cited by 5
Rucci, P., Avaldi, V. M., Travaglini, C., Ugolini, C., Berti, E., Moro, M. L., & Fantini, M. P. (2019) · PharmacoEconomics - Open · doi:10.1007/s41669-019-0166-8 · Cited by 5
Pagano, R., Ostolin, T. L. V. D. P., Fonseca, D. C., Marcadenti, A., Carvalho, A. P. P. F., Weber, B., Daltro, C., Lara, E. M. D. S., Nolêto, F. C. M., Bressan, J., et al. (2025) · Nutrients · doi:10.3390/nu17152518 · Cited by 4
Singh, S., Naicker, A., Grobbelaar, H., Singh, E., Spiegelman, D. L., & Shrestha, A. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21040389 · Cited by 4
Rittenhouse, B., Alolayan, S. O., Eguale, T., Segal, A. R., & Doucette, J. A. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107819 · Cited by 4
Position statement of the SEMI, SED, redGDPS, SEC, SEEDO, SEEN, SEMERGEN y SEMFYC
Huelgas, R. G., Peralta, F. G., Fernández, L. C., Galve, E., Casanueva, F. F., Puig‐Domingo, M., Bravo, J. J. M., Beltrán, D. O., Muñoz, J. E., Torre, E. L. M., et al. (2015) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2015.09.004 · Cited by 5
U.S. Preventive Services Task Force Criteria for Diabetes Screening
Aroda, V. R., & Fonseca, V. A. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.05.001 · Cited by 4
Smetana, G. W., Jones, D. B., & Wee, C. C. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0698 · Cited by 5
Khanal, S., Veerman, L. J., Nissen, L. M., & Hollingworth, S. (2018) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12265 · Cited by 4
Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?
Mainous, A. G., Yadav, S., Xie, Z., & Huo, J. S. (2020) · Family Medicine and Community Health · doi:10.1136/fmch-2019-000274 · Cited by 4
Hurst, T. E., McEwen, L. N., Joiner, K. L., & Herman, W. H. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002468 · Cited by 4
Hospitalizations reduce health care utilization of household members
Bergquist, S. L., & de Vaan, M. (2022) · Health Services Research · doi:10.1111/1475-6773.14050 · Cited by 4
Bailey, C. J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_8 · Cited by 4
Peso y diabetes tipo 2: nuevas recomendaciones
Gómez‐Huelgas, R. (2016) · Medicina Clínica · doi:10.1016/s0025-7753(17)30620-6 · Cited by 4
Yoga for Management of Type 2 Diabetes: A Review for Clinicians
Bonikowske, A. R., Schuver, K. J., & Lewis, B. A. (2017) · Journal of Clinical Exercise Physiology · doi:10.31189/2165-6193-6.3.50 · Cited by 5
Rodríguez, S. A., Meneses, A. L., Toboso, R. P. Q., & Moreno, I. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70418-3 · Cited by 9
FRADKIN, J. E., Wallace, J. A., & Rodgers, G. P. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.017 · Cited by 3
Herman, W. H., Tyndall, B. D., Duru, O. K., Moin, T., McEwen, L. N., Shao, H., Ackermann, R. T., Jacobs, S., Neuwahl, S. J., Kuo, S., et al. (2025) · AJPM Focus · doi:10.1016/j.focus.2025.100401 · Cited by 3
Effect of Health Plan Financial Incentive Offering on Employees with Prediabetes
Misra‐Hebert, A. D., Hu, B., Le, P. N. B., & Rothberg, M. B. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.09.024 · Cited by 3
Iranfar, N., & Smith, T. C. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.170158 · Cited by 4
Prävention von Adipositas und Diabetes mellitus als gesundheitspolitische Herausforderung
Effertz, T., Laxy, M., Schwettmann, L., Stratil, J. M., & von Philipsborn, P. (2018) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0038-1675252 · Cited by 4
Towards Autonomous Digital Health Coaching for Scalable Chronic Disease Prevention
Nolting, M., Roth, J., & Wittke, U. (2020) · International Conference on Pervasive Computing Technologies for Healthcare · doi:10.1145/3421937.3421966 · Cited by 4
Hassan, S., Sobers, N., Paul-Charles, J., Herbert, J., Dharamraj, K., Cruz, E., García-Rivera, E. J., Fredericks, L., Desai, M. M., Roy, S., et al. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100750 · Cited by 3
Prediabetes: An Undiagnosed Pandemic
Carris, N. W., & Corvin, J. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.10.004 · Cited by 3
Targeting the Mitochondrion in Diabetic Neuropathy
Hedayat, A. F., Chandrasekaran, K., Zilliox, L. A., & Russell, J. W. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_17 · Cited by 3
Prädiabetes als therapeutische Herausforderung in der Inneren Medizin
Kantartzis, K., Fritsche, A., & Birkenfeld, A. L. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01546-6 · Cited by 5
Jupiter, D. C., Zhang, Y., & Shibuya, N. (2024) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2024.05.013 · Cited by 3
Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was
Rittenhouse, B., Alolayan, S. O., Eguale, T., Segal, A. R., & Doucette, J. A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15851 · Cited by 3
Tsai, A. G., Juarez‐Colunga, E., Felton, S., Speer, R. B., Bessesen, D. H., & Atherly, A. J. (2015) · BMC Obesity · doi:10.1186/s40608-015-0054-4 · Cited by 3
Delivering triple prevention: a health system responsibility
Maruthappu, M. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00073-5 · Cited by 3
Gibbs, B. B., & Jakicic, J. M. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_12 · Cited by 3
Marshall, T. F., Groves, J. R., Holan, G. P., Lacamera, J., Choudhary, S., Pietrucha, R. J., & Tjokro, M. (2018) · American Journal of Lifestyle Medicine · doi:10.1177/1559827617750385 · Cited by 4
Impact of Health Insurance Policy on Diabetes Management
Myerson, R. M., Lu, T., Peters, A. L., Fox, S., & Huang, E. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-33286-0_31 · Cited by 3
Ledford, C. J. W., Fulleborn, S. T., Jackson, J. T., Rogers, T., & Samar, H. (2021) · Health Expectations · doi:10.1111/hex.13245 · Cited by 3
Translating patient related outcome measures into practice—lessons to be learnt
Majeed, W., & Thabit, H. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.03.11 · Cited by 3
Lin, Y., & Jiang, M. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s430847 · Cited by 3
Gamble, A., Khan, T., Hughes, A. G., Guo, Y., Vasaitis, S., Bidwell, J. H., & Christman, B. D. (2023) · JMIR Research Protocols · doi:10.2196/50183 · Cited by 2
Nolting, M., & Walsh, G. (2025) · International Journal of Intelligent Computing and Cybernetics · doi:10.1108/ijicc-03-2025-0122 · Cited by 5
We wait for disease to shout—What if we listened when biology whispered?
Rappaport, N., Schweickart, A., Hood, L., & Price, N. D. (2026) · Cell Systems · doi:10.1016/j.cels.2025.101509 · Cited by 2
Kalter-Leibovici, O., Zeidan, N. Y., Murad, H., Kimron, L., & Chetrit, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1786705 · Cited by 3
OJO: Fuzzy Logic based Digital Health Coaching for Scalable Diabetes Prevention
Nolting, M., & Wittke, U. (2019) · International Conference on Pervasive Computing Technologies for Healthcare · doi:10.1145/3329189.3329225 · Cited by 5
Bouchi, R., Izumi, K., Ohtsu, H., Miyo, K., Tanaka, S., Satoh‐Asahara, N., Hara, K., Odawara, M., Kusunoki, Y., Koyama, H., et al. (2021) · GHM Open · doi:10.35772/ghmo.2021.01004 · Cited by 2
Carter, E. W., Vadari, H. S., STOLL, S. C., Rogers, B., Resnicow, K., Heisler, M., Herman, W. H., Kim, H. M., McEwen, L. N., Volpp, K. G. M., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.107038 · Cited by 2
Cost-effectiveness of treatment intervention in prediabetic patients in Bulgaria
Yordanova, S., Mitov, K., & Kamusheva, M. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e110104 · Cited by 2
Morrow, L. M., Becker, F., Coleman, R. L., Gerstein, H. C., Rydén, L., Schöder, S., Gray, A. M., Leal, J., Holman, R. R., & for the ACE Study Group (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13473 · Cited by 2
MODERN APPROACH TO THE PREVENTION OF TYPE 2 DIABETES IN THE ELDERLY
Владиславовна, К. О., Bulgakova, S. V., Долгих, Ю. А., Sharonova, L. A., Тренева, Е. В., & Курмаев, Д. П. (2023) · Успехи геронтологии · doi:10.34922/ae.2023.36.4.013 · Cited by 2
Social Determinants of Diabetes
Kirk, K. F., McKinley, G. P., Mezuk, B. R., & Spears, E. C. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch67 · Cited by 3
Castellon‐Lopez, Y., Duru, O. K., Turk, N., Moreno, G., Norris, K. C., VU, A. V., Saju, R., Tseng, C., Jeffers, K. S., Mangione, C. M., et al. (2024) · Health Equity · doi:10.1089/heq.2023.0186 · Cited by 2
Peña, A., Olson, M. L., Putz, M. B., Siddique, A. B., Lish, E., Díaz, M., Ayers, S. L., McCullough, J. M., Williams, A. N., Patrick, D. L., et al. (2025) · Pediatric Obesity · doi:10.1111/ijpo.70046 · Cited by 2
Why We Should Screen for Type 2 Diabetes in High-Risk Patients
Kirkman, M. S. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.021 · Cited by 4
Rendas‐Baum, R., Wolden, M. L., Lay, A. L., & Bjørner, J. B. (2016) · Obesity · doi:10.1002/oby.21517 · Cited by 2
Health Ballistics: Multiple Reference Point Informed Probability Theory
Washburn, P. J. (2016) · International Journal of User-Driven Healthcare · doi:10.4018/ijudh.2016010102 · Cited by 2
Understanding Prediabetes in a Medicare Advantage Population Using Data Adaptive Techniques
Kamble, P., Collins, J. M., Harvey, R. A., PREWITT, T. G., Kimball, E. S., DeLuzio, T., Allen, E., & Bouchard, J. R. (2018) · Population Health Management · doi:10.1089/pop.2017.0165 · Cited by 4
METFORMIN EXERTS CARDIOPROTECTION IN ISOPROTERENOL-INDUCED CARDIOMYOPATHY IN RATS
Лой, Г. Я., Павлюк, Б. В., Крамар, С., Korda, M. M., & Oleshchuk, O. (2020) · Medical and Clinical Chemistry · doi:10.11603/mcch.2410-681x.2019.v.i4.10855 · Cited by 2
Participant food and activity costs in a translational Diabetes Prevention Program
Schafer, G., Songer, T. J., Arena, V. C., Kramer, M. K., Miller, R. G., & Kriska, A. M. (2020) · Translational Behavioral Medicine · doi:10.1093/tbm/ibaa031 · Cited by 2
Cefalu, W. T., Petersen, M. P., & Ratner, R. E. (2015) · Diabetes Care · doi:10.2337/dc15-0215 · Cited by 2
Management of obesity at worksites: less work for greater success?
Astrup, A. V. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.058339 · Cited by 3
Maki, D. G. (2017) · Annals of Internal Medicine · doi:10.7326/acpjc-2017-166-8-041 · Cited by 2
Perreault, L. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_2 · Cited by 1
Evaluation of the HealthImpact Diabetes Risk Model in the Veterans Health Administration
Linder, J. R., Waterbury, N. V., ALEXANDER, B. K., & Lund, B. C. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.9.862 · Cited by 1
Shao, H., Laxy, M., Gregg, E. W., Albright, A. L., & Zhang, P. (2020) · Value in Health · doi:10.1016/j.jval.2020.09.010 · Cited by 1
A Comparison of Mesenchymal Stem Cell Lineages for Treatment of Diabetes Mellitus
Sadowsky, D., Delijani, K., Asilnejad, B., Choi, J., & Steinberg, N. J. (2022) · Georgetown Medical Review · doi:10.52504/001c.31151 · Cited by 1
Thomas, J. J., Das, B. M., Lutes, L. D., Dickson, L., Holliday, P., Adams, B., & McNamee, H. (2024) · Diabetology · doi:10.3390/diabetology5070051 · Cited by 1
Ng, Z. L., Mahraj, K., Vallabh, S., Mehta, S. J., Chokshi, N. P., Schwartz, R., Hayes, B., Balasta, M. A., Volpp, K. G. M., & Press, M. J. (2025) · NEJM Catalyst · doi:10.1056/cat.24.0364 · Cited by 1
Has the Required Importance Been given to the Diagnosis and Treatment of Prediabetes?
Yuce, S., Cüre, E., Sezgin, H., Cüre, M. C., & Algün, E. (2014) · PubMed Central · Cited by 1
Clinical Aspects of Physical Exercise for Diabetic Patients: Theory and Practice
Sato, Y. (2012) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.24.259 · Cited by 1
Kann Lebensstilintervention Kosten sparen?
Schwarz, P. E. H. (2012) · Info Diabetologie · doi:10.1007/s15034-012-0118-1 · Cited by 1
Targeting Prediabetes to Preempt Diabetes
Nair, S., Rao, M., & Miraj, S. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00003-9 · Cited by 1
Rakel, D. P., Rindfleisch, J. A., & Gaudet, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00004-9 · Cited by 1
Gesundheitsökonomische Evaluation von Präventions- und Managementstrategien bei Diabetes
Laxy, M., & Kähm, K. (2019) · Der Diabetologe · doi:10.1007/s11428-019-0519-z · Cited by 1
Diabetic Neuropathy – Research
Chandrasekaran, K., Zilliox, L. A., & Russell, J. W. (2020) · Wiley eBooks · doi:10.1002/9781119309642.ch10 · Cited by 2
Kim, J. D., & Lee, W. (2020) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2020.2.e10 · Cited by 1
Buysschaert, M., & Bergman, M. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.06.022 · Cited by 2
The Role of Early and Later Response on Overall Outcomes in School‐Based Obesity Intervention
Arlinghaus, K. R., O’Connor, D. P., Ledoux, T. A., Hughes, S. O., & Johnston, C. A. (2020) · Obesity · doi:10.1002/oby.23040 · Cited by 1
Gamble, A., Beech, B. M., WADE, B. C., Sutton, V. D., Lim, C. S., Sandridge, S. W., & Welsch, M. A. (2021) · JMIR Research Protocols · doi:10.2196/25699 · Cited by 3
The National Jordanian Experts Consensus on Diagnosis and Treatment of Prediabetes
Abu-Hijleh, M. O., Annabi, F. A., Abujbara, M. A., Al-Khawaldeh, A., Haddad, F., HADDAD, J. A., Hyari, M. A. A., Howlett, H. C. S., Jarrah, N. S., Shegem, N. S., et al. (2021) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20210601.18 · Cited by 1
Management of type 2 diabetes without insulin: An update for the PCP
Thiruvengadam, S., & Peter, P. R. (2021) · Disease-a-Month · doi:10.1016/j.disamonth.2021.101290 · Cited by 1
(2022) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2022.1.146813 · Cited by 1
H-E-B, L., Ammerman, A., & Ryan, D. H. (2022) · NAM Perspectives · doi:10.31478/202209a · Cited by 1
Flagship initiatives to prevent and treat diabetes as a burden of western societies
Goulden, P., & Carvalho, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00018-5 · Cited by 1
Herman, W. H., Kuo, S., & Zhang, P. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16124 · Cited by 1
Mechanisms of action of aqueous extract from the Hunteria umbellata seed and metformin in diabetes
Ejelonu, O. C. (2019) · World Journal of Meta-Analysis · doi:10.13105/wjma.v7.i9.418 · Cited by 1
Editorial: diabetes, obesity and clinical inertia—the recipe for advanced NASH . Authors’ reply
Patel, Y. A., & Hunt, C. M. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14505 · Cited by 1
Mekniran, W., Brügger, V., Fuchs, M., Jin, Q., Wirth, B., Bilz, S., Brändle, M., Fleisch, E., Kowatsch, T., & Jovanova, M. (2026) · medRxiv · doi:10.64898/2026.02.10.26345992 · Cited by 1
Glycemic treatment of diabetes mellitus
Kaur, H., & Weinstock, R. S. (2014) · Wiley eBooks · doi:10.1002/9781118887837.ch4
Is Prediabetes a Risk Factor or is it a Disease?
Muthusamy, K., & Vella, A. V. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch1
Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges
Aroda, V. R., & Getaneh, A. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1054280
Jecht, M. (2015) · Der Diabetologe · doi:10.1007/s11428-015-0043-8
O’Donnell, M. P. (2016) · American Journal of Health Promotion · doi:10.1177/0890117116658442
Practice of Metabolic Medicine
Rothkopf, M. M., Haverstick, L. P., & Nusbaum, M. J. (2014) · CRC Press eBooks · doi:10.1201/b17616-4
Die Umsetzung von Diabetesprävention in der Praxis
Kulzer, B. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0950-9
Providing cost‐effective diabetes care
Chou, C., & Huang, E. S. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch37
Azzi, S. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22038
Metadata
- Authors
- The Diabetes Prevention Program Research Group
- Affiliations
- University of Michigan (US)
- Corresponding author
- The Diabetes Prevention Program Research Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-03-13
- Volume
- 35
- Issue
- 4
- Pages
- 723-730
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3308273
- OpenAlex
- W1896651021
- Cited by
- 436
- References
- 22
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 22 · 2023: 19 · 2022: 19 · 2021: 28 · 2020: 38 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 32 · 2014: 29 · 2013: 31 · 2012: 19
- FWCI
- 84.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092926, P30DK017047)
- National Center for Research Resources
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes prevention, lifestyle intervention, metformin, cost-effectiveness, Diabetes Prevention Program Outcomes Study, quality-adjusted life years, high-risk adults, direct medical costs, resource utilization (health care), health system perspective, societal perspective
- MeSH terms
- Adult, Combined Modality Therapy, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Prediabetic State, Prognosis, Time Factors, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Reduction Behavior, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.